| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 3,450 | 1,725 | 1,725 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 3443 SHS AFLAC | 48,075 | 201,037 |
| 1000 SHS INHIBIKASE THERAPEUTICS | 19,700 | 14,700 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ISHARES TRUST CORE MSCI EAFE ETF | AT COST | 373,954 | 426,194 |
| ISHARES S&P 500 ETF | AT COST | 1,121,081 | 1,830,211 |
| ISHARES S&P MID-CAP 400 INDEX ETF | AT COST | 426,211 | 627,871 |
| ISHARES CORE S&P SMALL-CAP ETF | AT COST | 431,110 | 542,434 |
| SCHWAB US DIVIDEND EQUITY ETF | AT COST | 499,911 | 533,882 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAXES | 409 | 0 | 0 | |
| FOREIGN TAX PAID | 260 | 260 | 0 |